| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Interferons | 7 | 2021 | 2885 | 1.05 | Why? |
| STAT2 Transcription Factor | 3 | 2020 | 141 | 1.01 | Why? |
| Viral Proteins | 13 | 2021 | 7370 | 0.94 | Why? |
| Nuclear Pore | 2 | 2021 | 49 | 0.92 | Why? |
| Peptide Elongation Factor 1 | 1 | 2021 | 38 | 0.89 | Why? |
| Depsipeptides | 1 | 2021 | 61 | 0.85 | Why? |
| Nuclear Pore Complex Proteins | 1 | 2020 | 53 | 0.85 | Why? |
| Immune Evasion | 6 | 2021 | 2081 | 0.83 | Why? |
| STAT1 Transcription Factor | 1 | 2020 | 313 | 0.73 | Why? |
| Interferon Type I | 7 | 2021 | 2789 | 0.69 | Why? |
| Respiratory Syncytial Virus Vaccines | 1 | 2018 | 104 | 0.67 | Why? |
| Flavivirus Infections | 1 | 2017 | 81 | 0.65 | Why? |
| DEAD Box Protein 58 | 5 | 2018 | 250 | 0.63 | Why? |
| Zika Virus | 3 | 2018 | 1924 | 0.62 | Why? |
| Zika Virus Infection | 3 | 2018 | 1920 | 0.59 | Why? |
| Flavivirus | 1 | 2017 | 182 | 0.58 | Why? |
| Influenza B virus | 2 | 2018 | 815 | 0.57 | Why? |
| Immunity, Innate | 12 | 2021 | 6570 | 0.54 | Why? |
| Reverse Genetics | 1 | 2018 | 439 | 0.54 | Why? |
| Respiratory Syncytial Viruses | 1 | 2018 | 612 | 0.53 | Why? |
| Viral Nonstructural Proteins | 9 | 2021 | 4810 | 0.52 | Why? |
| Influenza A virus | 5 | 2018 | 2234 | 0.49 | Why? |
| Transcription Factors | 6 | 2018 | 784 | 0.45 | Why? |
| Mice | 20 | 2021 | 21357 | 0.44 | Why? |
| Influenza Vaccines | 6 | 2021 | 2941 | 0.42 | Why? |
| RNA Polymerase II | 3 | 2018 | 29 | 0.42 | Why? |
| Animals | 47 | 2021 | 78931 | 0.41 | Why? |
| Host-Pathogen Interactions | 11 | 2021 | 11041 | 0.40 | Why? |
| HEK293 Cells | 12 | 2021 | 8394 | 0.40 | Why? |
| RNA Precursors | 2 | 2018 | 16 | 0.39 | Why? |
| Drug Evaluation, Preclinical | 5 | 2021 | 3347 | 0.39 | Why? |
| Interferon-beta | 7 | 2018 | 979 | 0.38 | Why? |
| Disease Models, Animal | 7 | 2020 | 10998 | 0.38 | Why? |
| Influenza, Human | 12 | 2021 | 10779 | 0.38 | Why? |
| A549 Cells | 9 | 2021 | 2066 | 0.37 | Why? |
| Virus Replication | 17 | 2021 | 14331 | 0.36 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2018 | 1234 | 0.36 | Why? |
| Vero Cells | 21 | 2021 | 14117 | 0.35 | Why? |
| RNA Helicases | 3 | 2021 | 413 | 0.33 | Why? |
| Active Transport, Cell Nucleus | 5 | 2021 | 203 | 0.32 | Why? |
| Interferon-Induced Helicase, IFIH1 | 3 | 2021 | 245 | 0.32 | Why? |
| Mice, Inbred C57BL | 5 | 2021 | 5542 | 0.31 | Why? |
| Trans-Activators | 2 | 2018 | 170 | 0.31 | Why? |
| Signal Transduction | 9 | 2021 | 7207 | 0.30 | Why? |
| Mutation | 6 | 2021 | 12376 | 0.30 | Why? |
| Influenza A Virus, H1N1 Subtype | 6 | 2021 | 2984 | 0.29 | Why? |
| Interferon Regulatory Factor-3 | 7 | 2021 | 379 | 0.28 | Why? |
| Methyltransferases | 1 | 2011 | 720 | 0.28 | Why? |
| Influenza A Virus, H5N1 Subtype | 2 | 2018 | 492 | 0.27 | Why? |
| Nucleocytoplasmic Transport Proteins | 2 | 2021 | 73 | 0.27 | Why? |
| Protein Interaction Maps | 3 | 2020 | 1333 | 0.27 | Why? |
| Viruses | 1 | 2017 | 2238 | 0.26 | Why? |
| Interferon Regulatory Factors | 2 | 2021 | 141 | 0.26 | Why? |
| Immunity, Humoral | 1 | 2018 | 4849 | 0.25 | Why? |
| Orthomyxoviridae Infections | 3 | 2019 | 1001 | 0.25 | Why? |
| Gene Expression Regulation, Viral | 2 | 2020 | 925 | 0.25 | Why? |
| Orthomyxoviridae | 3 | 2017 | 1168 | 0.25 | Why? |
| Drug Repositioning | 5 | 2021 | 5683 | 0.24 | Why? |
| Vaccines, Inactivated | 3 | 2020 | 1562 | 0.24 | Why? |
| Mice, Transgenic | 5 | 2021 | 2739 | 0.24 | Why? |
| Lipidoses | 1 | 2021 | 30 | 0.23 | Why? |
| Newcastle disease virus | 2 | 2020 | 108 | 0.22 | Why? |
| Antibodies, Viral | 10 | 2021 | 51949 | 0.22 | Why? |
| Immunity, Mucosal | 2 | 2021 | 426 | 0.22 | Why? |
| Cell Line | 11 | 2021 | 12040 | 0.22 | Why? |
| Topotecan | 1 | 2021 | 62 | 0.22 | Why? |
| Nuclear Matrix-Associated Proteins | 1 | 2020 | 50 | 0.22 | Why? |
| Phosphorylation | 4 | 2020 | 1060 | 0.22 | Why? |
| Topoisomerase I Inhibitors | 1 | 2021 | 63 | 0.22 | Why? |
| DNA Topoisomerases, Type I | 1 | 2021 | 86 | 0.21 | Why? |
| Phosphoproteins | 3 | 2021 | 4346 | 0.21 | Why? |
| Antiviral Agents | 10 | 2021 | 41703 | 0.21 | Why? |
| Sendai virus | 3 | 2017 | 111 | 0.21 | Why? |
| Cats | 3 | 2021 | 1890 | 0.21 | Why? |
| Nuclear Proteins | 3 | 2018 | 321 | 0.21 | Why? |
| Virus Shedding | 3 | 2021 | 5834 | 0.21 | Why? |
| Dialysis Solutions | 1 | 2020 | 76 | 0.21 | Why? |
| Influenza A Virus, H3N2 Subtype | 2 | 2017 | 572 | 0.20 | Why? |
| Gene Expression Regulation | 5 | 2021 | 4020 | 0.20 | Why? |
| Receptor, Interferon alpha-beta | 2 | 2020 | 610 | 0.20 | Why? |
| Terminator Regions, Genetic | 1 | 2018 | 3 | 0.20 | Why? |
| Vaccines, Attenuated | 4 | 2021 | 952 | 0.19 | Why? |
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2018 | 1 | 0.19 | Why? |
| Phospholipids | 1 | 2021 | 202 | 0.19 | Why? |
| Cross Reactions | 3 | 2021 | 4374 | 0.19 | Why? |
| RNA, Small Interfering | 3 | 2021 | 817 | 0.19 | Why? |
| Sigmodontinae | 1 | 2018 | 14 | 0.19 | Why? |
| Foot-and-Mouth Disease Virus | 1 | 2018 | 29 | 0.19 | Why? |
| Peptides, Cyclic | 1 | 2021 | 223 | 0.19 | Why? |
| Ferrets | 3 | 2020 | 1201 | 0.19 | Why? |
| Hemagglutination, Viral | 1 | 2018 | 31 | 0.19 | Why? |
| Proline | 1 | 2021 | 345 | 0.19 | Why? |
| Influenza A Virus, H7N7 Subtype | 1 | 2018 | 19 | 0.18 | Why? |
| Foot-and-Mouth Disease | 1 | 2018 | 35 | 0.18 | Why? |
| Cross Protection | 2 | 2019 | 373 | 0.18 | Why? |
| Tripartite Motif Proteins | 1 | 2018 | 44 | 0.18 | Why? |
| Loss of Function Mutation | 1 | 2020 | 244 | 0.18 | Why? |
| Hemagglutinins | 1 | 2019 | 143 | 0.18 | Why? |
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 239 | 0.18 | Why? |
| Paramyxoviridae | 1 | 2018 | 67 | 0.18 | Why? |
| Embryonic Stem Cells | 1 | 2018 | 66 | 0.18 | Why? |
| Myxovirus Resistance Proteins | 1 | 2018 | 77 | 0.18 | Why? |
| RNA-Binding Proteins | 4 | 2021 | 1022 | 0.18 | Why? |
| Protein Binding | 9 | 2021 | 11430 | 0.18 | Why? |
| Virulence Factors | 1 | 2021 | 338 | 0.18 | Why? |
| Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.18 | Why? |
| Chromatin | 1 | 2018 | 107 | 0.17 | Why? |
| Homeodomain Proteins | 1 | 2018 | 93 | 0.17 | Why? |
| Disease Susceptibility | 2 | 2021 | 4002 | 0.17 | Why? |
| Ducks | 1 | 2018 | 120 | 0.17 | Why? |
| RNA Splicing | 1 | 2018 | 119 | 0.17 | Why? |
| RNA, Viral | 11 | 2021 | 32276 | 0.17 | Why? |
| Endopeptidases | 1 | 2018 | 228 | 0.17 | Why? |
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 71 | 0.17 | Why? |
| RNA, Messenger | 4 | 2021 | 5131 | 0.17 | Why? |
| Cell Lineage | 1 | 2018 | 241 | 0.16 | Why? |
| Lung | 8 | 2021 | 31049 | 0.16 | Why? |
| Multiprotein Complexes | 1 | 2017 | 182 | 0.16 | Why? |
| Receptors, Immunologic | 5 | 2018 | 555 | 0.16 | Why? |
| Nucleotidyltransferases | 1 | 2017 | 77 | 0.16 | Why? |
| Quinolines | 1 | 2021 | 403 | 0.16 | Why? |
| Nanotubes | 1 | 2017 | 72 | 0.16 | Why? |
| Fetal Diseases | 1 | 2018 | 182 | 0.15 | Why? |
| DNA, Mitochondrial | 1 | 2017 | 163 | 0.15 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2018 | 249 | 0.15 | Why? |
| Antigens, CD | 1 | 2021 | 984 | 0.15 | Why? |
| Viral Envelope Proteins | 3 | 2017 | 3539 | 0.15 | Why? |
| Binding Sites | 4 | 2021 | 6201 | 0.15 | Why? |
| Humans | 65 | 2021 | 930598 | 0.15 | Why? |
| Imidazoles | 1 | 2021 | 631 | 0.15 | Why? |
| DEAD-box RNA Helicases | 2 | 2017 | 99 | 0.15 | Why? |
| Gene Deletion | 1 | 2017 | 430 | 0.15 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.15 | Why? |
| Mice, Knockout | 2 | 2018 | 1815 | 0.14 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 372 | 0.14 | Why? |
| West Nile Fever | 1 | 2017 | 166 | 0.14 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2017 | 385 | 0.14 | Why? |
| Movement | 1 | 2017 | 232 | 0.14 | Why? |
| Paramyxoviridae Infections | 1 | 2018 | 364 | 0.14 | Why? |
| Genome, Human | 1 | 2018 | 400 | 0.14 | Why? |
| Cat Diseases | 1 | 2020 | 539 | 0.14 | Why? |
| Peritoneal Dialysis | 1 | 2020 | 498 | 0.14 | Why? |
| Open Reading Frames | 1 | 2021 | 1898 | 0.13 | Why? |
| Adjuvants, Immunologic | 2 | 2021 | 1709 | 0.13 | Why? |
| SARS Virus | 5 | 2020 | 13021 | 0.13 | Why? |
| Plasma | 2 | 2021 | 1809 | 0.13 | Why? |
| Single-Domain Antibodies | 1 | 2020 | 744 | 0.13 | Why? |
| Antibody-Dependent Enhancement | 1 | 2017 | 413 | 0.12 | Why? |
| Intestinal Mucosa | 1 | 2021 | 1046 | 0.12 | Why? |
| Dengue Virus | 2 | 2017 | 910 | 0.12 | Why? |
| Neutralization Tests | 3 | 2020 | 6698 | 0.12 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.12 | Why? |
| Interferon Regulatory Factor-7 | 3 | 2020 | 234 | 0.12 | Why? |
| Stem Cells | 1 | 2018 | 595 | 0.12 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 3 | 2019 | 511 | 0.12 | Why? |
| Antigen-Presenting Cells | 1 | 2012 | 206 | 0.12 | Why? |
| Dendritic Cells | 2 | 2017 | 1330 | 0.12 | Why? |
| Models, Immunological | 1 | 2017 | 727 | 0.11 | Why? |
| RNA Interference | 3 | 2021 | 534 | 0.11 | Why? |
| Genome, Viral | 5 | 2021 | 13157 | 0.11 | Why? |
| Molecular Targeted Therapy | 1 | 2020 | 1579 | 0.11 | Why? |
| Molecular Mimicry | 1 | 2012 | 190 | 0.10 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.10 | Why? |
| Ebolavirus | 1 | 2017 | 834 | 0.10 | Why? |
| Receptors, Pattern Recognition | 1 | 2011 | 128 | 0.10 | Why? |
| Gene Expression | 1 | 2021 | 3332 | 0.10 | Why? |
| Interferon-alpha | 2 | 2009 | 1442 | 0.10 | Why? |
| Methylation | 1 | 2011 | 332 | 0.10 | Why? |
| Hemorrhagic Fever Virus, Crimean-Congo | 1 | 2011 | 133 | 0.10 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Ubiquitins | 1 | 2011 | 202 | 0.10 | Why? |
| HeLa Cells | 3 | 2018 | 1303 | 0.10 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.10 | Why? |
| Histones | 1 | 2012 | 371 | 0.10 | Why? |
| Cricetinae | 4 | 2021 | 3344 | 0.09 | Why? |
| Respiratory Mucosa | 1 | 2018 | 1522 | 0.09 | Why? |
| Proteomics | 1 | 2020 | 2481 | 0.09 | Why? |
| Adenosine Monophosphate | 3 | 2021 | 5652 | 0.09 | Why? |
| Alanine | 3 | 2021 | 5687 | 0.09 | Why? |
| Surface-Active Agents | 2 | 2021 | 267 | 0.09 | Why? |
| Virulence | 2 | 2018 | 2172 | 0.09 | Why? |
| Transcription, Genetic | 4 | 2018 | 1326 | 0.09 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.09 | Why? |
| Viral Load | 5 | 2021 | 15850 | 0.09 | Why? |
| Female | 20 | 2021 | 380317 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.09 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.09 | Why? |
| Dengue | 2 | 2017 | 1565 | 0.08 | Why? |
| Placenta | 1 | 2018 | 1531 | 0.08 | Why? |
| Cells, Cultured | 4 | 2021 | 5835 | 0.08 | Why? |
| Drug Synergism | 2 | 2021 | 833 | 0.08 | Why? |
| Mice, Inbred BALB C | 4 | 2021 | 5814 | 0.08 | Why? |
| Single-Cell Analysis | 1 | 2017 | 2450 | 0.08 | Why? |
| Proto-Oncogene Proteins | 2 | 2020 | 340 | 0.08 | Why? |
| Immunity | 1 | 2018 | 2651 | 0.08 | Why? |
| Liver | 1 | 2021 | 4007 | 0.08 | Why? |
| Lymphocytic choriomeningitis virus | 1 | 2006 | 98 | 0.08 | Why? |
| Madin Darby Canine Kidney Cells | 2 | 2019 | 640 | 0.08 | Why? |
| Protein Interaction Mapping | 2 | 2020 | 487 | 0.08 | Why? |
| Dogs | 3 | 2019 | 2529 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.08 | Why? |
| Vaccines, DNA | 2 | 2020 | 871 | 0.08 | Why? |
| Gastrointestinal Diseases | 1 | 2021 | 2580 | 0.07 | Why? |
| Hepatitis, Viral, Animal | 1 | 2007 | 274 | 0.07 | Why? |
| Induced Pluripotent Stem Cells | 2 | 2021 | 584 | 0.07 | Why? |
| Golgi Apparatus | 2 | 2021 | 178 | 0.07 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.07 | Why? |
| Shigella flexneri | 1 | 2004 | 14 | 0.07 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.07 | Why? |
| Carrier Proteins | 2 | 2018 | 513 | 0.07 | Why? |
| Coronavirus | 2 | 2011 | 18339 | 0.07 | Why? |
| Protein Transport | 3 | 2010 | 487 | 0.06 | Why? |
| Cytokines | 5 | 2021 | 15010 | 0.06 | Why? |
| Peptide Hydrolases | 1 | 2011 | 1269 | 0.06 | Why? |
| Mass Spectrometry | 2 | 2020 | 1165 | 0.06 | Why? |
| Cryoelectron Microscopy | 2 | 2020 | 2372 | 0.06 | Why? |
| New York City | 3 | 2021 | 7432 | 0.06 | Why? |
| Endoplasmic Reticulum | 2 | 2021 | 430 | 0.06 | Why? |
| Transfection | 2 | 2021 | 864 | 0.06 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.06 | Why? |
| Serine Endopeptidases | 1 | 2018 | 4606 | 0.06 | Why? |
| Phylogeny | 2 | 2020 | 13341 | 0.06 | Why? |
| Cytoplasm | 2 | 2017 | 304 | 0.06 | Why? |
| Cations | 1 | 2021 | 77 | 0.06 | Why? |
| DNA-Binding Proteins | 1 | 2005 | 469 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.06 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.06 | Why? |
| Vaccines, Live, Unattenuated | 1 | 2020 | 28 | 0.06 | Why? |
| Dose-Response Relationship, Drug | 2 | 2021 | 3776 | 0.06 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.05 | Why? |
| Antigens, Viral | 1 | 2018 | 6298 | 0.05 | Why? |
| Transcription Factor RelA | 1 | 2021 | 122 | 0.05 | Why? |
| Toll-Like Receptor 8 | 1 | 2021 | 102 | 0.05 | Why? |
| SKP Cullin F-Box Protein Ligases | 1 | 2020 | 130 | 0.05 | Why? |
| Brain | 1 | 2018 | 5133 | 0.05 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2018 | 5164 | 0.05 | Why? |
| Cyclin-Dependent Kinases | 1 | 2020 | 124 | 0.05 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2020 | 238 | 0.05 | Why? |
| THP-1 Cells | 1 | 2021 | 374 | 0.05 | Why? |
| Casein Kinase II | 1 | 2020 | 120 | 0.05 | Why? |
| Receptors, sigma | 1 | 2020 | 167 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Male | 14 | 2021 | 367725 | 0.05 | Why? |
| GPI-Linked Proteins | 1 | 2021 | 317 | 0.05 | Why? |
| Protein Conformation, beta-Strand | 1 | 2021 | 414 | 0.05 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2017 | 5837 | 0.05 | Why? |
| Cleavage And Polyadenylation Specificity Factor | 1 | 2018 | 6 | 0.05 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.05 | Why? |
| CCCTC-Binding Factor | 1 | 2018 | 6 | 0.05 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.05 | Why? |
| Autopsy | 2 | 2021 | 3495 | 0.05 | Why? |
| Inflammation Mediators | 2 | 2021 | 2654 | 0.05 | Why? |
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2018 | 1 | 0.05 | Why? |
| Hydrazones | 1 | 2020 | 216 | 0.05 | Why? |
| Virus Release | 1 | 2021 | 253 | 0.05 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2021 | 530 | 0.05 | Why? |
| RNA, Double-Stranded | 1 | 2021 | 226 | 0.05 | Why? |
| Introns | 1 | 2018 | 112 | 0.05 | Why? |
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 33 | 0.05 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 230 | 0.05 | Why? |
| Genetic Loci | 1 | 2020 | 439 | 0.05 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2020 | 243 | 0.05 | Why? |
| Multienzyme Complexes | 1 | 2018 | 43 | 0.05 | Why? |
| Nuclear Factor 90 Proteins | 1 | 2017 | 1 | 0.05 | Why? |
| Y-Box-Binding Protein 1 | 1 | 2017 | 3 | 0.05 | Why? |
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2017 | 15 | 0.05 | Why? |
| Morpholines | 1 | 2020 | 351 | 0.05 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.04 | Why? |
| Exosome Multienzyme Ribonuclease Complex | 1 | 2017 | 5 | 0.04 | Why? |
| Triazines | 1 | 2020 | 246 | 0.04 | Why? |
| Conserved Sequence | 1 | 2020 | 751 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 347 | 0.04 | Why? |
| RNA Processing, Post-Transcriptional | 1 | 2018 | 110 | 0.04 | Why? |
| Genetic Complementation Test | 1 | 2017 | 59 | 0.04 | Why? |
| Chromatin Immunoprecipitation | 1 | 2017 | 53 | 0.04 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Medical Waste Disposal | 1 | 2020 | 221 | 0.04 | Why? |
| Murine hepatitis virus | 1 | 2007 | 1720 | 0.04 | Why? |
| Mice, Mutant Strains | 1 | 2017 | 42 | 0.04 | Why? |
| Toll-Like Receptor 3 | 1 | 2020 | 391 | 0.04 | Why? |
| Protein Stability | 1 | 2020 | 756 | 0.04 | Why? |
| Virus Internalization | 3 | 2021 | 7921 | 0.04 | Why? |
| Primates | 1 | 2020 | 584 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.04 | Why? |
| Chick Embryo | 1 | 2017 | 249 | 0.04 | Why? |
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 78 | 0.04 | Why? |
| Geography, Medical | 1 | 2020 | 537 | 0.04 | Why? |
| Polymerization | 1 | 2017 | 46 | 0.04 | Why? |
| Vaccines, Virus-Like Particle | 1 | 2020 | 312 | 0.04 | Why? |
| DNA Replication | 1 | 2017 | 121 | 0.04 | Why? |
| Genetic Vectors | 2 | 2020 | 1600 | 0.04 | Why? |
| Chile | 1 | 2021 | 1095 | 0.04 | Why? |
| Toll-Like Receptor 7 | 1 | 2021 | 402 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Actins | 1 | 2017 | 108 | 0.04 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2017 | 207 | 0.04 | Why? |
| Cytoskeleton | 1 | 2017 | 99 | 0.04 | Why? |
| Metabolome | 1 | 2021 | 624 | 0.04 | Why? |
| Cloning, Molecular | 1 | 2020 | 1036 | 0.04 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.04 | Why? |
| Cholesterol | 1 | 2021 | 660 | 0.04 | Why? |
| Hep G2 Cells | 1 | 2017 | 391 | 0.04 | Why? |
| Cell Culture Techniques | 1 | 2021 | 704 | 0.04 | Why? |
| Ubiquitination | 1 | 2018 | 343 | 0.04 | Why? |
| Epithelial Cells | 2 | 2021 | 3508 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2020 | 1236 | 0.04 | Why? |
| Membrane Glycoproteins | 2 | 2021 | 2273 | 0.04 | Why? |
| Cell Cycle Proteins | 1 | 2018 | 297 | 0.04 | Why? |
| Coculture Techniques | 1 | 2017 | 258 | 0.04 | Why? |
| Polyethylene Glycols | 1 | 2021 | 574 | 0.04 | Why? |
| Receptors, Fc | 1 | 2017 | 153 | 0.04 | Why? |
| Guinea Pigs | 1 | 2017 | 420 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2018 | 8843 | 0.04 | Why? |
| Stochastic Processes | 1 | 2017 | 369 | 0.04 | Why? |
| Neutrophils | 1 | 2012 | 5476 | 0.04 | Why? |
| Protein Biosynthesis | 1 | 2020 | 653 | 0.04 | Why? |
| Cell Nucleus | 2 | 2009 | 399 | 0.04 | Why? |
| Ribosomes | 1 | 2017 | 200 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| West Nile virus | 1 | 2017 | 206 | 0.04 | Why? |
| Antibody Affinity | 1 | 2020 | 1078 | 0.04 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2017 | 349 | 0.04 | Why? |
| Molecular Docking Simulation | 2 | 2021 | 6902 | 0.04 | Why? |
| Metabolomics | 1 | 2021 | 921 | 0.04 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.04 | Why? |
| Longitudinal Studies | 2 | 2021 | 9893 | 0.04 | Why? |
| Neuraminidase | 1 | 2017 | 289 | 0.03 | Why? |
| Adenoviridae | 1 | 2020 | 1151 | 0.03 | Why? |
| Alleles | 1 | 2020 | 1557 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2017 | 1027 | 0.03 | Why? |
| Immunization | 2 | 2019 | 2019 | 0.03 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.03 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.03 | Why? |
| Flavonoids | 1 | 2018 | 492 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2021 | 2134 | 0.03 | Why? |
| Cysteine Proteinase Inhibitors | 1 | 2020 | 675 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2021 | 2275 | 0.03 | Why? |
| Virus Attachment | 1 | 2020 | 1259 | 0.03 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.03 | Why? |
| Trachea | 1 | 2018 | 894 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Exoribonucleases | 1 | 2017 | 455 | 0.03 | Why? |
| Adult | 8 | 2021 | 244371 | 0.03 | Why? |
| Pyrimidines | 1 | 2020 | 1557 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2021 | 2886 | 0.03 | Why? |
| Alveolar Epithelial Cells | 1 | 2020 | 1445 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2018 | 11559 | 0.03 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.03 | Why? |
| Plasmids | 2 | 2006 | 840 | 0.03 | Why? |
| Piperidines | 1 | 2018 | 795 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Small Molecule Libraries | 1 | 2020 | 1060 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Hepacivirus | 1 | 2021 | 1509 | 0.03 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.03 | Why? |
| Neurodegenerative Diseases | 1 | 2017 | 469 | 0.03 | Why? |
| Exosomes | 1 | 2017 | 567 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2021 | 3786 | 0.03 | Why? |
| Protein Kinase Inhibitors | 1 | 2020 | 1585 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Protein Conformation | 1 | 2020 | 4386 | 0.02 | Why? |
| Hepatitis C | 1 | 2021 | 1514 | 0.02 | Why? |
| Protein Structure, Quaternary | 1 | 2011 | 455 | 0.02 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2018 | 2290 | 0.02 | Why? |
| Ubiquitin | 1 | 2011 | 243 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.02 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2021 | 4155 | 0.02 | Why? |
| Microscopy, Immunoelectron | 1 | 2007 | 49 | 0.02 | Why? |
| Lymphocyte Activation | 1 | 2017 | 2742 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
| Proteome | 1 | 2018 | 1812 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.02 | Why? |
| Cytoplasmic Vesicles | 1 | 2007 | 74 | 0.02 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 2426 | 0.02 | Why? |
| Protein Structure, Secondary | 1 | 2011 | 1077 | 0.02 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.02 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2012 | 3198 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.02 | Why? |
| Protein Structure, Tertiary | 1 | 2011 | 1565 | 0.02 | Why? |
| Computational Biology | 1 | 2021 | 4514 | 0.02 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2007 | 249 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.02 | Why? |
| Convalescence | 1 | 2017 | 2829 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.02 | Why? |
| RNA Stability | 1 | 2007 | 285 | 0.02 | Why? |
| Ovarian Neoplasms | 1 | 2011 | 465 | 0.02 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.02 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.02 | Why? |
| Liposomes | 1 | 2006 | 334 | 0.02 | Why? |
| DNA | 1 | 2010 | 778 | 0.02 | Why? |
| Microscopy, Electron | 1 | 2007 | 830 | 0.02 | Why? |
| Structure-Activity Relationship | 1 | 2011 | 2219 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Crystallography, X-Ray | 1 | 2011 | 2689 | 0.02 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2017 | 21571 | 0.02 | Why? |
| Fibroblasts | 1 | 2007 | 839 | 0.02 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Cell Membrane | 1 | 2007 | 743 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Amino Acid Sequence | 1 | 2012 | 6049 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.01 | Why? |
| Administration, Intranasal | 1 | 2004 | 1132 | 0.01 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Base Sequence | 1 | 2004 | 3581 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Nucleocapsid Proteins | 1 | 2007 | 3120 | 0.01 | Why? |
| Vaccination | 1 | 2019 | 19050 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |